Hypoglycemia (low blood sugar) is a pervasive problem for people with diabetes. In the United States, complications from low blood sugar account for at least 245,000 emergency room visits annually and are a major barrier to optimal glycemic control.
Physicians should consider the potential impact insulin and sulfonylureas may require additional education or a specialized care plan to address the potential impact of hypoglycemia on their quality of life.
The Endocrine Society has developed the following evidence-based clinical practice guidelines to help clinicians identify patients at risk for hypoglycemic events and to improve the care of their patients with diabetes:
The Endocrine Society has made reducing the incidence of hypoglycemia and raising public awareness a top priority. We are working with other specialty societies, patient advocates, federal agencies, payers, and industry partners to identify barriers to optimal care and potential solutions. In 2015, the Society and its partners created a Blueprint that provides a comprehensive framework for addressing hypoglycemia in the United States. Through this effort, we identified opportunities where we can have the greatest impact in addressing hypoglycemia and we are currently developing a quality improvement project to improve patient care.
Quality Improvement One-Pager
Presentation on the Project
According to the National Institute of Diabetes and Digestive and Kidney Diseases: "Hypoglycemia, also called low blood glucose or low blood sugar, occurs when the level of glucose in your blood drops below normal. Symptoms of hypoglycemia tend to come on quickly and can vary from person to person...Sometimes people don’t feel any symptoms."